D Milliner

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. ncbi Phenotypic expression of primary hyperoxaluria: comparative features of types I and II
    D S Milliner
    Division of Nephrology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Kidney Int 59:31-6. 2001
  2. ncbi Treatment of the primary hyperoxalurias: a new chapter
    D Milliner
    Mayo Clinic Hyperoxaluria Center, Rochester, Minnesota 55905, USA
    Kidney Int 70:1198-200. 2006
  3. ncbi Stones, bones, and heredity
    Dawn S Milliner
    Division of Nephrology, Mayo Clinic Hyperoxaluria Centre, Mayo Clinic College of Medicine, Rochester, Minnisota 55905, USA
    Acta Paediatr Suppl 95:27-30. 2006
  4. ncbi The primary hyperoxalurias: an algorithm for diagnosis
    Dawn S Milliner
    Mayo Clinic Hyperoxaluria Center, Division of Nephrology, Department of Pediatric and Adolescent Medicine, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
    Am J Nephrol 25:154-60. 2005
  5. ncbi Outcomes and complications of pregnancy in women with primary hyperoxaluria
    Suzanne M Norby
    Division of Nephrology, Mayo Clinic, Rochester, MN 55905, USA
    Am J Kidney Dis 43:277-85. 2004
  6. ncbi Comprehensive mutation screening in 55 probands with type 1 primary hyperoxaluria shows feasibility of a gene-based diagnosis
    Carla G Monico
    Mayo Clinic Hyperoxaluria Center and Department of Internal Medicine, Division of Nephrology, Mayo Clinic College of Medicine, Rochester, MN 55902, USA
    J Am Soc Nephrol 18:1905-14. 2007
  7. ncbi Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass
    Wayne K Nelson
    Mayo Medical School, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Surg Obes Relat Dis 1:481-5. 2005
  8. ncbi Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or II
    Carla G Monico
    Division of Nephrology, General Clinical Research Center, Mayo Clinic Rochester, Minnesota 55905, USA
    Kidney Int 62:392-400. 2002
  9. ncbi International registry for primary hyperoxaluria
    John C Lieske
    Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
    Am J Nephrol 25:290-6. 2005
  10. ncbi Early subclinical coronary artery calcification in young adults who were pediatric kidney transplant recipients
    Michael B Ishitani
    William J von Liebig Transplant Center, Mayo Medical School, Foundation and Clinic, Rochester, MN, USA
    Am J Transplant 5:1689-93. 2005

Research Grants

  1. 7th International Workshop on Primary Hyperoxaluria
    Dawn Milliner; Fiscal Year: 2005
  2. Prevention of Renal Damage in Primary Hyperoxaluria
    Dawn Milliner; Fiscal Year: 2007

Collaborators

Detail Information

Publications18

  1. ncbi Phenotypic expression of primary hyperoxaluria: comparative features of types I and II
    D S Milliner
    Division of Nephrology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Kidney Int 59:31-6. 2001
    ..Marked hyperoxaluria results in urolithiasis, renal failure, and systemic oxalosis. A direct comparison of PHI and PHII has not previously been available...
  2. ncbi Treatment of the primary hyperoxalurias: a new chapter
    D Milliner
    Mayo Clinic Hyperoxaluria Center, Rochester, Minnesota 55905, USA
    Kidney Int 70:1198-200. 2006
    ..Oxalobacter formigenes is a promising new therapy with potential to induce secretion of oxalate into the intestinal lumen, where it can be degraded by the bacteria...
  3. ncbi Stones, bones, and heredity
    Dawn S Milliner
    Division of Nephrology, Mayo Clinic Hyperoxaluria Centre, Mayo Clinic College of Medicine, Rochester, Minnisota 55905, USA
    Acta Paediatr Suppl 95:27-30. 2006
    ..These disorders of calcium urolithiasis illustrate the value of molecular medicine for diagnosis and the promise it provides for innovative and more effective future treatments...
  4. ncbi The primary hyperoxalurias: an algorithm for diagnosis
    Dawn S Milliner
    Mayo Clinic Hyperoxaluria Center, Division of Nephrology, Department of Pediatric and Adolescent Medicine, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
    Am J Nephrol 25:154-60. 2005
    ..Clinicians are likely to encounter few PH patients during a practicing lifetime. Definitive diagnosis requires special studies performed in only a small number of laboratories worldwide. Accordingly, delays in diagnosis are common...
  5. ncbi Outcomes and complications of pregnancy in women with primary hyperoxaluria
    Suzanne M Norby
    Division of Nephrology, Mayo Clinic, Rochester, MN 55905, USA
    Am J Kidney Dis 43:277-85. 2004
    ..This study sought to determine the number and outcomes of pregnancies in a series of women with PH-I and PH-II, to assess the incidence of complications during pregnancy, and to characterize infant outcomes...
  6. ncbi Comprehensive mutation screening in 55 probands with type 1 primary hyperoxaluria shows feasibility of a gene-based diagnosis
    Carla G Monico
    Mayo Clinic Hyperoxaluria Center and Department of Internal Medicine, Division of Nephrology, Mayo Clinic College of Medicine, Rochester, MN 55902, USA
    J Am Soc Nephrol 18:1905-14. 2007
    ..Also reported here is previously unavailable evidence for the pathogenic basis of all AGXT missense variants, including evolutionary conservation data in a multisequence alignment and use of a normal control population...
  7. ncbi Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass
    Wayne K Nelson
    Mayo Medical School, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Surg Obes Relat Dis 1:481-5. 2005
    ..CONCLUSION: Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy must be considered with the other risks of RYGBP. Efforts should be made to identify factors that predispose patients to developing hyperoxaluria...
  8. ncbi Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or II
    Carla G Monico
    Division of Nephrology, General Clinical Research Center, Mayo Clinic Rochester, Minnesota 55905, USA
    Kidney Int 62:392-400. 2002
    ..Hepatic glycolate oxidase (GO) is a candidate enzyme for a third form of inherited hyperoxaluria...
  9. ncbi International registry for primary hyperoxaluria
    John C Lieske
    Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
    Am J Nephrol 25:290-6. 2005
    ..Primary hyperoxaluria (PH) is an inherited disorder that causes calcium urolithiasis and renal failure. Due to its rarity, experience at most centers with this disease is limited...
  10. ncbi Early subclinical coronary artery calcification in young adults who were pediatric kidney transplant recipients
    Michael B Ishitani
    William J von Liebig Transplant Center, Mayo Medical School, Foundation and Clinic, Rochester, MN, USA
    Am J Transplant 5:1689-93. 2005
    ..These data suggest young adults who received pediatric kidney transplants are at increased risk for developing early CAC and need close monitoring to detect early CAD so as to prevent premature cardiac morbidity and mortality...
  11. ncbi Implications of genotype and enzyme phenotype in pyridoxine response of patients with type I primary hyperoxaluria
    Carla G Monico
    Mayo Clinic Hyperoxaluria Center, Division of Pediatric Nephrology, Department of Pediatric and Adolescent Medicine, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
    Am J Nephrol 25:183-8. 2005
    ..Two patients showed responses varying from this pattern. To further clarify the molecular basis of VB6 response in PHI, we performed additional genotyping...
  12. ncbi Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele
    Carla G Monico
    Mayo Clinic College of Medicine, Mayo Clinic Foundation, Rochester, Minnesota 55905, USA
    Kidney Int 67:1704-9. 2005
    ..Mechanisms of VB6 action on hepatic alanine:glyoxylate aminotransferase (AGT), the deficient enzyme in PHI, and VB6 dose response have not been well-characterized...
  13. ncbi Sonographically guided percutaneous radio frequency ablation of a renal cell carcinoma in a transplanted kidney
    J William Charboneau
    Department of Radiology, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Ultrasound Med 21:1299-302. 2002
    ..Radio frequency ablation is an effective treatment for focal renal cell carcinoma (RCC). We report a patient with RCC in a transplanted kidney that was successfully treated with percutaneous sonographically guided radio frequency ablation...
  14. ncbi Glyoxylate reductase activity in blood mononuclear cells and the diagnosis of primary hyperoxaluria type 2
    John Knight
    Department of Urology, Wake Forest University School of Medicine, Medical Center Blvd, Winston Salem, NC 27157, USA
    Nephrol Dial Transplant 21:2292-5. 2006
    ..In this study, we have evaluated the potential of determining GR and d-glycerate dehydrogenase (DGDH) activity in blood mononuclear cells (BMC) as a diagnostic indicator of PH2...
  15. ncbi Hand-assisted laparoscopic donor nephrectomy for pediatric kidney allograft recipients
    Dean Y Kim
    Department of Surgery, Division of Transplantation Surgery, William J. von Liebig Transplant Center, Mayo Medical School, Foundation and Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Pediatr Transplant 8:460-3. 2004
    ..In conclusion, hand-assisted LDN is a safe method of procuring kidneys from potential donors with no significant negative outcomes to the pediatric recipients...
  16. ncbi The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein
    Christopher J Ward
    Division of Nephrology, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA
    Nat Genet 30:259-69. 2002
    ..Fibrocystin may be a receptor protein that acts in collecting-duct and biliary differentiation...
  17. ncbi Pediatric renal-replacement therapy--coming of age
    Dawn S Milliner
    Division of Pediatric Nephrology, Mayo Clinic, Rochester, Minn, USA
    N Engl J Med 350:2637-9. 2004
  18. ncbi Renal artery intervention in pediatric and adolescent patients: a 20-year experience
    Ying Huang
    Division of Vascular Surgery, Gonda Vascular Center, Mayo Clinic, Rochester, Minnesota 55905, USA
    Vasc Endovascular Surg 41:490-9. 2007
    ..The authors conclude that both OR and PTRA benefit pediatric patients. PTRA for selected patients may be promising as a first line treatment or as a bridge to definitive OR in children with small arteries...

Research Grants5

  1. 7th International Workshop on Primary Hyperoxaluria
    Dawn Milliner; Fiscal Year: 2005
    ..Recent crystallization of the AGT protein, and advances in the molecular genetics, diagnostic testing, and pharmacogenomics of PH make 2004 an exciting year for the 7th Workshop. ..
  2. Prevention of Renal Damage in Primary Hyperoxaluria
    Dawn Milliner; Fiscal Year: 2007
    ..Clinical data, samples, and research protocols completed via the Registry will allow rapid testing of hypotheses and promote worldwide collaboration to advance the care of PH patients. ..